Carboplatin/Paclitaxel Induction in Ovarian Cancer: The Finer Points
August 15th 2018The regimen consisting of carboplatin and paclitaxel represents the backbone of ovarian cancer treatment. Here, we reflect on our experience administering the carboplatin/paclitaxel regimen to scores of ovarian cancer patients over the past decade and a half.